DrugPatentWatch Database Preview
Details for Patent: 6,465,504
Which drugs does patent 6,465,504 protect, and when does it expire?
Patent 6,465,504 protects JADENU SPRINKLE, EXJADE, and JADENU, and is included in three NDAs.
This patent has forty-eight patent family members in thirty-four countries.
Summary for Patent: 6,465,504
| Title: | Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| Abstract: | The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I ##STR1## in which R.sub.1 -R.sub.5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals. |
| Inventor(s): | Lattmann; Rene (Binningen, SE), Acklin; Pierre (Basel, SE) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 09/699,765 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,465,504 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; |
Drugs Protected by US Patent 6,465,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharms Corp | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-001 | May 18, 2017 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | |||
| Novartis Pharms Corp | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-002 | May 18, 2017 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | |||
| Novartis Pharms Corp | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-003 | May 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
| Novartis | EXJADE | deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882-001 | Nov 2, 2005 | AB | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,465,504
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 1593/96 | Jun 25, 1996 |
International Family Members for US Patent 6,465,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 1127 | Start Trial | |||
| African Regional IP Organization (ARIPO) | 9801407 | Start Trial | |||
| Argentina | 007479 | Start Trial | |||
| Austria | 226435 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
